The story
In 1960 Peter Nowell of the University of Pennsylvania and David Hungerford of the Institute for Cancer Research in Philadelphia, who was then a graduate student, reported an unusually small chromosome in the white blood cells of patients with chronic myeloid leukemia (CML). It was named the Philadelphia chromosome after the city. It was the first consistent chromosomal abnormality ever linked to a human cancer, and it suggested that cancer could be caused by specific changes in a cell's genes.
The finding was possible because of a technical advance: in 1956 Joe Hin Tjio and Albert Levan had established that humans have 46 chromosomes, and improved methods let scientists spread and count chromosomes under the microscope. In 1973 Janet Rowley showed the small chromosome was the result of a swap of material between chromosomes 9 and 22, called a translocation. In the 1980s researchers found that this swap fuses two genes, BCR and ABL, creating a hybrid gene that produces an enzyme stuck in the on position, driving cells to multiply. Imatinib, sold as Gleevec, blocks the enzyme, and the U.S. approved it in 2001. Before it, CML was usually fatal within a few years for most patients; today most patients on treatment have a near-normal life expectancy.
Why it mattered
- It was the first proof that a specific genetic change could cause cancer, supporting the idea that cancer is a genetic disease.
- It led to the discovery of the BCR-ABL fusion gene and to the idea of cancer-causing oncogenes.
- It led directly to Gleevec, the first successful targeted cancer drug, in 2001.
- It encouraged the search for genetic targets across cancers, shaping modern precision oncology.
Sources
- The Philadelphia Chromosome: History and Implications for the Future Fox Chase Cancer Center
- How imatinib transformed leukemia treatment National Cancer Institute
- Peter C. Nowell, MD AACR
Drafted by AI (Claude) from the sources above and checked against them by AI; no historian has reviewed this page. Spot a mistake? Suggest a correction. How pages are made
Community notes
Loading notes…